Download presentation
Presentation is loading. Please wait.
1
Frontotemporal Lobar Degeneration:
Clinical Features, Subtypes and Pathology Brad Boeve MD Department of Neurology Mayo Clinic Rochester, Minnesota USA
2
FTLD: Clinical Features, Subtypes and Pathology
Objectives Review the key aspects of FTLD: Clinical features Subtypes Pathology
3
FTLD: Clinical Features, Subtypes and Pathology
Clinical Features of Each Syndrome naPPA Nonfluent/ agrammatic variant svPPA semantic variant Behavioral Variant FTD lvPPA logopenic variant Fluent speech Decreased word comprehension and recognition of objects,people Halting speech Short phrases Grammar errors Cognitive loss Disinhibition Inflexibility Decreased insight Spontaneous but slow speech output Word retrieval problems Corticobasal Syndrome FTD -Motor Neuron Disease/ALS Cognitive loss Behavior impairment Motor symptoms Cognitive & memory loss Asymmetric rigidity Apraxia Progressive Supranuclear Palsy Motor symptoms Upper and/or lower motorneuron pathways Behavioral & cognitive loss Parkinsonism Eye movement disturbances ALS
4
FTLD: Clinical Features, Subtypes and Pathology
Syndrome – Pathology Associations naPPA Nonfluent/ agrammatic variant svPPA semantic variant Behavioral Variant FTD lvPPA logopenic variant FTLD-Tau more than FTLD-TDP43 or AD pathology Left posterior frontal Lobe, insula FTLD-TDP43 Frontal/ventral Temporal lobe FTLD-Tau (3R) FTLD-TDP43 Prefrontal lobe Temporal lobe AD pathology more than FTLD-Tau or TDP43 Left post/supr temporal lobe & Medial parietal Corticobasal Syndrome FTD -Motor Neuron Disease/ALS FTLD-TDP43 FTLD-FUS Cortex, Motor neurons FTLD-Tau (4R) more than AD pathology Frontal, temporal lobe, Basal ganglia Progressive Supranuclear Palsy TDP43, SOD1,FUS Upper, lower MNs FTLD-Tau (4R) Basal ganglia Brainstem ALS
5
FTLD: Clinical Features, Subtypes and Pathology
Syndrome – Pathology Associations TAU TDP FUS AD tau protein TAR DNA binding protein Fused in sarcoma protein Alzheimer’s Disease pathology
6
FTLD: Clinical Features, Subtypes and Pathology
Behavioral Variant Frontotemporal Dementia (bvFTD) Clinical Features Apathy Loss of empathy Disinhibited behavior Mental rigidity Diminished insight Executive dysfunction
7
FTLD: Clinical Features, Subtypes and Pathology
Behavioral Variant Frontotemporal Dementia (bvFTD) Brain-Behavioral Relationships L R L
8
FTLD: Clinical Features, Subtypes and Pathology
Primary Progressive Aphasia – Semantic Variant Clinical Features Prominent naming difficulties Loss of word meaning
9
FTLD: Clinical Features, Subtypes and Pathology
Primary Progressive Aphasia – Agnosia Variant Clinical Features Prominent visual agnosia (loss of visual meaning of faces or objects) Later develop naming difficulties
10
FTLD: Clinical Features, Subtypes and Pathology
Primary Progressive Aphasia – Variant Comparison prosopagnosia/associative agnosia semantic variant PPA
11
FTLD: Clinical Features, Subtypes and Pathology
Primary Progressive Aphasia – Nonfluent Variant Clinical Features Slow, halting speech Grammatical and articulatory errors Short phrases
12
FTLD: Clinical Features, Subtypes and Pathology
Primary Progressive Aphasia – Logopenic Variant Clinical Features Slower speech Word retrieval problems Difficulties with repeating statements/questions
13
FTLD: Clinical Features, Subtypes and Pathology
Primary Progressive Aphasia – Summary L naPPA TAU TDP AD lvPPA AD Tau TDP svPPA TDP Tau AD
14
FTLD: Clinical Features, Subtypes and Pathology
ALS - Terminology Terms all mean same disorder: Amyotrophic lateral sclerosis (ALS) Motor neuron disease (MND) Lou Gehrig’s disease
15
FTLD: Clinical Features, Subtypes and Pathology
ALS Clinical Features Altered speech Muscle weakness and atrophy Arm and/or gait difficulties Pseudobulbar affect
16
FTLD: Clinical Features, Subtypes and Pathology
ALS Brain-Behavioral Relationships L L L
17
FTLD: Clinical Features, Subtypes and Pathology
FTD-ALS Clinical Features FTD Apathy Loss of empathy Disinhibited behavior Mental rigidity Diminished insight Executive dysfunction ALS Altered speech Muscle weakness and atrophy Arm and/or gait difficulties Pseudobulbar affect
18
FTLD: Clinical Features, Subtypes and Pathology
FTD-ALS Brain-Behavioral Relationships L R L
19
FTLD: Clinical Features, Subtypes and Pathology
Corticobasal Syndrome (CBS) Distinctive Clinical Features Progressive Asymmetric Rigidity Apraxia “Cortical” Apraxia Myoclonus Cortical sensory loss Alien limb phenomenon AOS/aphasia Visuospatial deficits “Basal” Rigidity Dystonia Fisted hand
20
FTLD: Clinical Features, Subtypes and Pathology
Corticobasal Syndrome (CBS) Topography of Degeneration L L L L R L
21
FTLD: Clinical Features, Subtypes and Pathology
Progressive Supranuclear Palsy Syndrome/Richardson’s Syndrome Distinctive Clinical Features Parkinsonism Vision problems Gait impairment and falls Other Features Speech changes Swallowing changes Pseudobulbar palsy Executive dysfunction
22
FTLD: Clinical Features, Subtypes and Pathology
Progressive Supranuclear Palsy Syndrome/Richardson’s Syndrome Topography of Degeneration L L L
23
FTLD: Clinical Features, Subtypes and Pathology
Conclusions The symptoms and behaviors reflect the disease and DO NOT define the person The symptoms match the location of degeneration in the brain far better than the underlying dysfunctional protein or genetic associations This variability of symptoms and dysfunctional protein will make future treatment decisions challenging
24
FTLD: Clinical Features, Subtypes and Pathology
Future Directions Improve ability to accurately establish a diagnosis as early as possible Improve management and quality of life for patients and families Develop better biomarkers for tau vs TDP-43 vs Alzheimer’s disease Plan for disease-modifying therapies
Similar presentations
